NYXH — Nyxoah SA
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1857190 ·
Belgium
Last close
$1.71
Market Cap
$171.12M
52W High
$3.42
52W Low
$1.26
ADV30
555,666
Next earnings
2026-08-05
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 6,372,000 | 3,638,000 | -20,503,000 | -15,944,000 | 97,598,000 | 12,934,000 | 61,727,000 |
| Dec 2025 | 5,644,000 | 3,625,000 | -18,259,000 | -23,513,000 | 118,471,000 | 30,001,000 | 69,342,000 |
| Sep 2025 | 1,972,000 | 1,193,000 | -24,195,000 | -23,580,000 | 93,599,000 | 10,869,000 | 42,645,000 |
| Jun 2025 | 1,340,000 | 850,000 | -19,850,000 | -20,607,000 | 116,470,000 | 22,729,000 | 43,073,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-59,359,000
Investing CF
$785,000
Financing CF
$71,767,000
CapEx
$-3,783,000
Dividends Paid
$0
Buybacks
—
EPS Diluted TTM
$-2.37
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$-306,029,000
Inventory
$4,660,000
Receivables
$7,578,000
ST Investments
$18,000,000
EBIT TTM
$-87,385,000
Pretax Income TTM
$-89,076,000
Interest Exp TTM
$1,691,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$15,328,000
EBITDA
$-82,043,000
Free Cash Flow
$-45,774,752
Enterprise Value
$83,062,216
Total Cash
$25,934,000
Total Debt
$36,080,000
Shares Out
100,072,815
Trailing EPS
$-2.43
Book Value
$0.94
ROE
-130.0%
ROA
-44.6%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 10,020,000 | -82,942,000 | -90,085,000 | 118,471,000 | 69,342,000 | — | -68,979,000 |
| Dec 2024 | 4,521,000 | -58,809,000 | -59,236,000 | 158,406,000 | 45,152,000 | — | -49,226,000 |
| Dec 2023 | 4,348,000 | -45,102,000 | -43,212,000 | 124,157,000 | 26,135,000 | — | -44,778,000 |
| Dec 2022 | 3,084,000 | -32,499,000 | -31,225,000 | 146,071,000 | 25,747,000 | — | -28,756,000 |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-1.21
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| STXS | Stereotaxis, Inc. | $166.15M | $1.70 | — |
| INGN | Inogen Inc | $177.07M | $6.54 | — |
| APYX | Apyx Medical Corp | $184.44M | $4.38 | — |
| LUCD | Lucid Diagnostics Inc. | $190.77M | $1.00 | — |
| EMBC | Embecta Corp. | $192.22M | $3.24 | — |
News headlines (Yahoo Finance, 1h cache)
Nyxoah Touts Genio U.S. Launch Traction, Reimbursement Stability at Investor Day
2026-07-10 23:02 · Yahoo
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Capital Raise And Analyst Caution
2026-07-08 09:15 · Yahoo
Nyxoah Announces Preliminary Results for the Second Quarter of 2026
2026-07-07 20:05 · Yahoo
Information on the total number of voting rights and shares
2026-06-30 20:30 · Yahoo
Publication relating to transparency notifications
2026-06-29 20:30 · Yahoo
Nyxoah (ENXTBR:NYXH) Stock Fair Value Moves Lower After Analyst Cuts And Capital Concerns
2026-06-24 04:30 · Yahoo
Nyxoah to Host Investor Day in New York on July 8, 2026
2026-06-23 20:05 · Yahoo
Invitation to attend the extraordinary shareholders’ meeting of the Company to be held on July 9, 2026
2026-06-19 20:30 · Yahoo
Nyxoah Receives $15 Million from the European Investment Bank
2026-06-17 20:05 · Yahoo
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
2026-06-15 20:05 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.